Related Experiment Videos
Challenges associated with evaluating the clinical utility of non-cytotoxic pharmaceutical agents in oncology
Journal of Cancer Research and Clinical Oncology
|January 1, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Apical hypertrophic cardiomyopathy: A case series at a Brazilian referral center with a maximal follow-up of 15 years.
Annales de cardiologie et d'angeiologie·2021
Platinum-Gemcitabine-Avastin (PGA) for platinum-resistant/refractory ovarian cancer.
European journal of gynaecological oncology·2018
Intravenous vitamin C in the supportive care of cancer patients: a review and rational approach.
Current oncology (Toronto, Ont.)·2018
Surgical intervention in relapsed ovarian cancer is beneficial: contra.
Annals of oncology : official journal of the European Society for Medical Oncology·2013
The use of bevacizumab in the management of ovarian cancer: an argument for single-agent rather than combination therapy.
Annals of oncology : official journal of the European Society for Medical Oncology·2011
Evaluation of novel targeted small-molecule therapeutics in desmoplastic small round cell tumor (DSRCT) cells.
Journal of cancer research and clinical oncology·2026
Longer-term response to SARS-CoV-2 vaccination after allogeneic blood stem cell transplantation.
Journal of cancer research and clinical oncology·2026
Comment on "Treatment of retroperitoneal sarcoma in Germany between 2000 and 2022: a retrospective analysis from the German Cancer Registry Group".
Journal of cancer research and clinical oncology·2026
Comment on "Theranostic lipid nanocarriers for precision diagnosis and targeted therapy in pancreatic ductal adenocarcinoma".
Journal of cancer research and clinical oncology·2026
Sleep quality and disturbances in adolescents and young adults with cancer compared to a healthy comparison group: results of the AYA-LE study.
Journal of cancer research and clinical oncology·2026
Senomorphic miR-3155b suppresses the senescence-associated secretory phenotype in therapy-induced senescence.
Frontiers in cell and developmental biology·2026
Predictive biomarkers for precision treatment in rheumatoid arthritis: are we there yet?
Frontiers in pharmacology·2026
Oncolytic reovirus: tumor-microenvironment remodeling, engineering constraints, and translational strategies.
Frontiers in immunology·2026
Profiling crystal engineered ligands for targeting treatment resistant androgen receptors.
Frontiers in pharmacology·2026